Large vancomycin overdose in two premature infants with minimal toxicity

American Journal of Perinatology

Volumn 21, Issue 8, 2004, Pages 433-438

  Miner, Lonnie J ^a   Faix, Roger G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Nephrotoxicity; Ototoxicity; Overdose; Premature infant; Vancomycin

Indexed keywords

AMPICILLIN; CEFOTAXIME; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG OVERDOSE; FEMALE; HUMAN; INFANT; NEPHROTOXICITY; NEWBORN SEPSIS; OTOTOXICITY; PREMATURITY; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; TOXICOKINETICS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MEDICATION ERRORS; OVERDOSE; VANCOMYCIN;

EID: 9744263254     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-835959     Document Type: Article

References (42)

1. Griffith RS. Introduction to vancomycin. Rev Infect Dis 1981;3(suppl):S200-S204
2. Brown R, Wise W. Vancomycin: a reappraisal. BMJ 1982;284:1508-1509
3. Elting LS, Rubenstein EB, Kurtin D, et al. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer 1998;83:2597-2607
4. Geraci JF. Vancomycin. Mayo Clin Proc 1977;52:631-634
5. Walker RW, Heaton A. Thrombocytopenia due to vancomycin. Lancet 1985;1:932
6. Mackett RL, Guay DR. Vancomycin-induced neutropenia. Can Med Assoc J 1985;132:39-40
7. Wilhelm MP. Vancomycin. Mayo Clin Proc 1991;66:1165-1170
8. Cole DR, Oliver M, Coward RA, Brown CB. Allergy, red man syndrome and vancomycin. Lancet 1985;2:80
9. Farber BF, Moellering RC Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138-141
10. Woodley DW, Hall WH. Treatment of severe staphylococcal infections with vancomycin. Ann Intern Med 1961;55:235-249
11. Bailie GR, Neal D. Vancomycin ototoxicity and nephrotoxicity: a review. Med Toxicol Adverse Drug Exp 1988;3:376-386
12. Appel GB, Neu HC. The nephrotoxicity of antimicrobial agents. N Engl J Med 1977;296:722-729
13. Wenzel RP. The emergence of methicillin resistant Staphylococcus aureus. Ann Intern Med 1982;97:440-442
14. Brummett RE. Ototoxicity of vancomycin and analogues. Otolaryngol Clin North Am 1993;26:821-828
15. Hook EW III, Johnson WD. Vancomycin therapy of bacterial endocarditis. Am J Med 1978;65:411-415
16. Mellor JA, Kingdom J, Cafferkey M, Keane CT. Vancomycin toxicity: a prospective study. J Antimicrob Chemother 1985;15:773-780
17. Gendeh BS, Gibb AG, Aziz NS, et al. Vancomycin administration in continuous ambulatory hemodialysis: the risk of ototoxicity. Otolaryngol Head Neck Surg 1998;118:551-558
18. Brummett RE, Fox KE. Vancomycin- and erythromycin-induced hearing loss in humans. Antimicrob Agents Chemother 1989;33:791-796
19. Cantu TG, Yamanaka-Yuen NA, Lietman PS. Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis 1994;19:1180-1182
20. De Hoog M, van Zanten BA, Hop WC, et al. Newborn hearing screening: tobramycin and vancomycin are not factors for hearing loss. J Pediatr 2003;142:41-46
21. Masur H, Francioli P, Ruddy M, Murray HW. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clin Nephrol 1983;20:85-88
22. Burkhart KK, Metcalf S, Shurnas E, et al. Exchange transfusion and multidose activated charcoal following vancomycin overdose. J Toxicol Clin Toxicol 1992;30:285-294
23. Bunchman TE, Valentini RP, Gardner J, et al. Treatment of vancomycin overdose using high-efficiency dialysis membranes. Pediatr Nephrol 1999;13:773-774
24. Akil IÖ, Mir S. Hemodiafiltration for vancomycin overdose in a patient with end-stage renal failure. Pediatr Nephrol 2001;16:1019-1021
25. Walczyk MH, Hill D, Arai A, Wolfson M. Acute renal failure owing to inadvertent vancomycin overdose. Vancomycin removal by continuous arteriovenous hemofiltration. Ann Clin Lab Sci 1988;18:440-443
26. Panzarino VM, Feldstein TJ, Kashtan CE. Charcoal hemoperfusion in a child with vancomycin overdose and chronic renal failure. Pediatr Nephrol 1998;12:63-64
27. Goebel J, Ananth M, Lewy JE. Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure. Pediatr Nephrol 1999;13:423-425
28. Lutz H, Lenarz T, Weidauer H, Federspil P, Hoth S. Ototoxicity of vancomycin: an experimental study in guinea pigs. ORL J Otorhinolaryngol Relat Spec 1991;53:273-278
29. Nishihara K, Shimizu T, Kotaki H, et al. Lack of effect of vancomycin and gentamicin on auditory function in guinea pigs. Antimicrob Agents Chemother 1996;40:1098-1103
30. Tange RA, Lieviet HL, Marle J, et al. An experimental study of vancomycin-induced cochlear damage. Arch Otorhinolaryngol 1989;246:67-70
31. Davis RR, Brummett RE, Bendrkk TW, Himes DL. The ototoxic interaction of viomycin, capreomycin, and polymyxicn B with ethacrynic acid. Acta Otolaryngol 1982;93:211-217
32. Brummett RE, Fox KE, Jacobs F, et al. Augmented gentamicin ototoxicity induced by vancomycin in guinea pigs. Arch Otolaryngol Head Neck Surg 1990;116:61-64
33. Aronoff GR, Sloan RS, Dinwiddie CB Jr, et al. Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother 1981;19:306-308
34. Cohen E, Dadashev A, Drucker M, et al. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. J Antimicrob Chemother 2002;49:155-160
35. Wood CA, Kohlhepp SJ, Kohnen PW, et al. Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrob Agents Chemother 1986;30:20-24
36. Goetz MB, Sayers J. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J Antimicrob Chemother 1993;32:325-334
37. Sorrell TC, Collignon PJ. A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother 1985;16:235-241
38. Rybak MJ, Albrecht LM, Boike SC, Chanresekar PH. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother 1990;25:679-687
39. Goren MP, Baker DK Jr, Shenep JL. Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children. Pediatr Infect Dis J 1989;8:278-282
40. Nakata MC. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Chemotherapy 1987;33:302-304
41. Hall JW, Brown DP, Mackey-Hargadine JR. Pediatric applications of serial auditory brainstem and middle latency evoked response recordings. Int J Pediatr Otorhinolaryngol 1985;9:201-218
42. Müller D, Hufnagel M, Suttorp M. Accidental overdose of vancomycin in preterm twins. Pediatr Infect Dis J 1999;18:744-745